Atara Biotherapeutics Provides a Business Update

Stock Information for Atara Biotherapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Atara Biotherapeutics Inc.

Atara Biotherapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Operational Progress
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
Atara Biotherapeutics Provides Regulatory Update on Tabelecleucel
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Atara Biotherapeutics, Inc. - ATRA
Atara Biotherapeutics Provides Regulatory and Business Update on EBVALLO(TM) (tabelecleucel)

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.